The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model

Patients with coronavirus disease 2019 (COVID-19) have been frequently reported to exhibit neurological manifestations and disruption of the blood-brain barrier (BBB). Among the risk factors for BBB breakdown, the loss of endothelial cells and pericytes has caused widespread concern. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Jiahang, Su, Yuwen, Zhou, You, Wei, Hui, Xu, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445123/
https://www.ncbi.nlm.nih.gov/pubmed/36082238
http://dx.doi.org/10.3389/fncel.2022.897564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445123/
https://www.ncbi.nlm.nih.gov/pubmed/36082238
http://dx.doi.org/10.3389/fncel.2022.897564

Ejemplares similares